Literature DB >> 6246006

Mecillinam and ampicillin separately or combined in gram-negative septicemia.

E Ekwall, A Scheja, S Cronberg, K Ganrot-Norlin, M Jonsson, I Juhlin, G Kahlmeter, A Thorén, K E Thulin, G Tunevall.   

Abstract

Of 20 patients with gram-negative septicemia treated with mecillinam alone or in combination with ampicillin, successful therapeutic results were obtained in 16. In 11 patients treated with ampicillin alone, three failures responded successfully to a combination of mecillinam and ampicillin. Mecillinam MIC values of isolated Enterobacteriaceae were 0.05-0.4 micrograms/ml. In patients receiving 5 mg/kg mecillinam intravenously every six hours, the mean 0.5 hour concentration was 11.0 micrograms/ml and in those given 10 mg/kg 23.3 migcrograms/ml. No serious side effects were recorded. One patient on mecillinam developed an exanthema, as did three patients on combined therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246006     DOI: 10.1007/bf01677397

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

1.  Pharmacokinetic and therapeutic studies of pivmecillinam in patients with normal and impaired renal function.

Authors:  M Ekberg; T Denneberg; S Larsson; I Juhlin
Journal:  Scand J Infect Dis       Date:  1978

2.  Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds.

Authors:  H C Neu
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

3.  In vivo activity of the 6beta-amidinopenicillanic acid derivative, mecillinam, chemically linked or combined in varying ratios with 6-aminopenicillanic acid derivatives.

Authors:  E Grunberg; R Cleeland
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

4.  The mechanism of action of mecillinam.

Authors:  B G Spratt
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

5.  6 -amidinopenicillanic acids--a new group of antibiotics.

Authors:  F Lund; L Tybring
Journal:  Nat New Biol       Date:  1972-04-05

6.  Pivmecillinam in the treatment of Salmonella carriers.

Authors:  M Jonsson
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

7.  The treatment of enteric fever with mecillinam.

Authors:  A M Geddes; P D Clarke
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

8.  Controlled randomized study comparing amoxycillin and pivmecillinam in adult out-patients presenting with symptoms of acute urinary tract infection.

Authors:  B Bresky
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

  8 in total
  2 in total

1.  Multiple-dose pharmacokinetics of amdinocillin in healthy volunteers.

Authors:  S L Barriere; J G Gambertoglio; E T Lin; J E Conte
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

Review 2.  Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review.

Authors:  Filip Jansåker; Niels Frimodt-Møller; Thomas L Benfield; Jenny Dahl Knudsen
Journal:  Infect Drug Resist       Date:  2018-05-24       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.